The U.S. hospice market size was estimated at USD 31.25 billion in 2025 and is predicted to increase from USD 32.72 billion in 2026 to approximately USD 49.51 billion by 2035, expanding at a CAGR of 4.71% from 2026 to 2035. The expansion of the market is due to the rising prevalence of chronic diseases among rapidly growing geriatric populations.

U.S. Hospice Market Statical Scope

Hospice services represent cost-effective and compassionate care solutions typically provided to patients in the final phase of life. These individuals often have exhausted medical treatment options for incurable diseases such as cancer, lung disease, congestive heart failure, and dementia.

In the U.S., the number of hospice centers has steadily increased in recent years, a trend largely driven by an aging population and a growing prevalence of chronic diseases that elevate demand for hospice services. Furthermore, the market is experiencing a notable shift towards home-based care, propelled by technological advancements and changing patient preferences.

U.S. Hospice Market Share, By Type, 2025, (%)

• Routine Home Care - The routine home care segment dominates at 93%, as it constitutes the most prevalent form of hospice care, providing comfort and support to patients in their residences.
• Continuous Home Care - The continuous home care segment holds 3%, offering intensive care during crisis periods.
• Inpatient Respite Care- The inpatient respite care segment accounts for 2%, granting temporary relief to caregivers and reducing caregiver burnout.
• General Inpatient Care- The general inpatient care segment also holds 2%, catering to patients necessitating more intensive healthcare services.

U.S. Hospice Market Share, By Service Location, 2025, (%)

• Hospice centres - Hospice centres dominate with 87%, as they serve as the primary venues for hospice care, offering specialized services and 24-hour support.
• Hospital - The hospital segment accounts for 6%, wherein hospitals provide hospice services for patients requiring additional medical assistance.
• Home Hospice Care - The home hospice care segment comprises 5%, allowing patients to receive care within the comfort of their own homes during their final days.
• Skilled Nurse Facility - Skilled nursing facilities hold 2% and provide hospice care within nursing homes equipped for comprehensive medical care.

U.S. Hospice Market Share, By Diagnosis, 2025, (%)

• Dementia- dementia segment claims the leading segment at 26%, being one of the most prevalent conditions necessitating hospice care, alongside specialized end-of-life care requirements.
• Circulatory/Heart- The circulatory and heart condition segment holds 21%, representing the second most common diagnosis for hospice care.
• Cancer- The cancer segment, at 18%, remains a leading cause for hospice services, particularly in the advanced stages of the disease.
• Respiratory - Increasing cases due to pollution and lifestyle factors, with a 10% share, support the market but remain limited.
• Stroke - Serious health condition with moderate prevalence, with a 8% share, contributes but does not surpass leading segments.
• Chronic Kidney Disease - Lower prevalence compared to major diseases, with a 6% share, restricts overall market contribution.
• Others - Includes various additional conditions, with a 11% share, result in moderate contribution.

Top Companies in the U.S. Hospice Market

• Chemed Corporation (VITAS Healthcare)
• LHC Group, Inc. (UnitedHealth Group)
• Amedisys
• Gentiva
• Brookdale Senior Living, Inc
• Crossroads Hospice (Agape Care Group)
• Seasons Hospice
• Oklahoma Palliative & Hospice Care
• Compassus
• Chapters Health System

Segments Covered in the Report

By Type

• Routine Home Care
• Continuous Home Care
• Inpatient Respite Care
• General Inpatient Care

By Location

• Hospice Center
• Hospital
• Home Hospice Care
• Skilled Nursing Facility

By Diagnosis

• Dementia
• Circulatory/Heart
• Cancer
• Respiratory
• Stroke
• Chronic Kidney Disease
• Others